Items where authors include "Lalloo, D.G."

Article

Khoo, S.H. orcid.org/0000-0002-2769-0967, FitzGerald, R. orcid.org/0000-0003-0227-4200, Edwards, C.J. orcid.org/0000-0002-8233-6602 et al. (52 more authors) (2026) A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection. Journal of Antimicrobial Chemotherapy, 81 (7). dkag180. ISSN 0305-7453

Rowland, T. orcid.org/0000-0001-5059-065X, FitzGerald, R. orcid.org/0000-0003-0227-4200, Challenger, E. orcid.org/0000-0002-8978-6067 et al. (29 more authors) (2026) Optimal dose and safety of intravenous favipiravir in hospitalized patients with COVID-19: a dose-escalating, randomized controlled phase Ib study. Clinical Pharmacology & Therapeutics, 119 (6). pp. 1650-1661. ISSN 0009-9236